Scientific Publications

Rogers, C; Shen, Y; Burgoyne, D; Piers, E. Studies Toward the Synthesis of Contignasterol: Functionalization of the Steroidal A B Ring System. Synthetic Communications. (December 2001) 2001 32 (9) Kuriakose, N; Rebstein, P; Bechard, J; Kasserra, C. IPL 576,092 is a novel steroidal anti-inflammatory compound with a mechanism of action distinct from that of glucocorticoids. American Academy of Asthma, Allergy and Immunology, New Orleans, LA, USA. (March 2001)



Kasserra, C; Harris, P; Dumdei, E. Prevention of allergen induced rat lung eosinophilia with IPL 576,092, a novel anti-inflammatory steroid devoid of glucocorticoid binding. American Academy of Asthma, Allergy and Immunology, New Orleans, LA, USA. (March 2001)



Langlands, J; Abraham, W; Harris, P; Kasserra, C. Marked reductions in both early and late phase responses to allergen challenge in animal models of asthma with IPL 576,092. American Academy of Asthma, Allergy and Immunology, New Orleans, LA, USA. (March 2001)



Rebstein, P; Zhou, Y; Yao, J; Lai-How, A; Abraham, S; Burgoyne, D; Shen, Y; Lauener, R. Inhibition of phosphodiesterase 4 and neutrophil ROS production by compounds incorporating a 3-alkyloxy-4-methoxy-phenyl side-chain. Gordon Research Conference on Cyclic Nucleotide Phosphodiesterases, Queen's College, Oxford, UK. (September 10 -15, 2000)



Rogers, C; Shen, Y; Burgoyne, D; Piers, E. Studies Toward the Synthesis of Contignasterol: Functionalization of the Steroidal A B Ring System. 220th ACS National Meeting, Washington, D.C., USA. (August 20-24, 2000) Kasserra, C; Bechard, J; Harris, P; Kuriakos, N; Langlands, J. IPL576: A Novel Class of Anti-inflammatory Compounds for the Treatment of Asthma. Keystone Symposia on Molecular & Cellular Biology, ASTHMA Incline Village, Nevada, USA.(January 9-15, 1999)